Docetaxel

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Dostępny od:

REX Medical Ltd

INN (International Nazwa):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

Dawkowanie:

20 mg/mL

Forma farmaceutyczna:

Concentrate for infusion

Skład:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Sztuk w opakowaniu:

Vial, glass, Diluent, 1.5 mL

Klasa:

Prescription

Typ recepty:

Prescription

Wyprodukowano przez:

Cipla Ltd

Wskazania:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Podsumowanie produktu:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Data autoryzacji:

2006-06-23